(AGENPARL) – mar 07 febbraio 2023 31 January 2023
FOR IMMEDIATE RELEASE
Pfizer Q4 earnings: Pfizer has plundered health systems for profit, campaigners say
Responding to Pfizer’s Q4 earnings, Julia Kosgei, Policy Co-Lead for the People’s Vaccine Alliance, said:
“In one year alone, Pfizer’s revenue has exceeded the total health expenditure of more than 100 countries combined. If it were a country, Pfizer would sit in the wealthiest third of nation-states. And it has amassed this fortune while jacking up prices on COVID-19 vaccines amid a pandemic that has devastated people’s livelihoods. Put simply, Pfizer has plundered health systems for profit.
“Billions of people in developing countries still cannot access affordable COVID-19 medicines. Companies like Pfizer are gobbling up ever-greater proportions of health budgets and handing the spoils to wealthy shareholders – all while treating access for developing countries as little more than a PR initiative. We cannot go on like this.
“This week, the WHO will reveal the ‘zero draft’ of a pandemic treaty. Governments must use this opportunity to stand up to the pandemic profiteers and demand that, in a health emergency, public health comes before private profit.”
/Ends
Notes to editors
This is a reaction to Pfizer’s Q4 earnings announcement: [https://investors.pfizer.com/Investors/News/news-details/2023/PFIZER-REPORTS-RECORD-FULL-YEAR-2022-RESULTS-AND-PROVIDES-FULL-YEAR-2023-FINANCIAL-GUIDANCE/default.aspx](http://tracking.vuelio.co.uk/tracking/click?d=rE8JssA6oGX_Zh302U8UPuRaXlXJPJTO0VXYvInVETtd2A4_4VyTiBTjqGWSoZPihXd0T1INpphSOIh1Sokm33DLsRbUXKTensdU2KiqvdUXStAdRi5IH-oNaX4ad23NnWacUlkaEdawC65KcxQFTu77NtyBT-QjQJrc6MdlmcSDzJNjkF2_Qm8OpvsjzezAMXKgnd8PSRLF0cvxzQkDbAuG8abm4Lz8nelulXI1rqgMaBA157bZZu66gNvZVHbZl08ex4O-JsQ7fTxLInGgdpxhALP15u2xXde6Sq5rbTOW2zwPVIj1cS6Cxa1IOMEbzw2)
According to the World Health Organization Global Health Expenditure Database, the combined health expenditure of the bottom 108 countries equalled $97 billion (2020 figures): [https://apps.who.int/nha/database](http://tracking.vuelio.co.uk/tracking/click?d=ccmVLt-Ge7PqelP6BNqF7yrETUzat7VcPPz8Cg87AFgB2FL_wnwOaTY4yo4Fc1l79zA5rXDScmyg7urd5wxnupEqj73eQR5mcQ9rzogdyCtF5PYosepB138Zw9dHsoR8Ki0_pBN9IE-9LF4ezpnf_SQ1)
Pfizer’s $100.3bn in revenue would place it 63rd of 190 in [Worldometer](http://tracking.vuelio.co.uk/tracking/click?d=iWLZWJU-1goGzaV8tFvlCgG1-dOajeJznVa4rqltRaRR5jfgCRWIxgPyokOGnzexc65jUw6mgElHYyWijxLiNMFQzk43OnnZRI1mve5LHjSnIaFtqT82eEn8H8FCR7dptZkkGwYBgAV3dVOoNmOO7Scn26W1BAtZCGhTlgN3AErKB-YPDYaC6H-dV1ynLmo7xjnasQ7FqaTIBErkFYPoM0uK5ON1dm73mEmRLDWgSxQcWLG26ufEk9iG69GgbUDVTQiJkJpLIurixEzEeUxW_kmYrOmedZal1cbOsoPRL79Sh3SzgLTrVW2I8mbkb4M0gz347-VgulkaKLJD7xLSPnguQazHHfsbQY51khAPAj3K8MNSDLnFX_uQI8yDbbUQR-STH0XEBZ3f-5Kx_BSWT75pAw_KzNUGhF8_woZHAwIuBp1ZvCQsDszI5Phbj9qFElVkaEuSrJtc-mEo1Qwit-gcW62Hme8eEz3hZGPjjkZ1aXdUUdwnUjVU4CPc6FjnSPQnuddP6yDnhk6wE1iPkxy_n0wG9keclk0Dzc-mv9rgbrrtBC_XzFS_6RFlQ-MfyPk5RyDr3z2TZCA0sy49yKJflxucUu7jyJb0zuQ7cL0qyb8yqqptgXianQwugd-IJmWvzSh0Ugd5VZwQ1GEOK3hRXARnZuN0qGaFmaKR7N8F0)’s ranking of countries by GDP, within the top third: [https://www.worldometers.info/gdp/gdp-by-country/](http://tracking.vuelio.co.uk/tracking/click?d=CKDrnbvxD1VL8ziT-VlUIinHTaxOkFNE-x2QHjOpsXZ_bhoo7vZEA8SQZji8TT8-fSQSLF4tbWOYrUm10Mrq665v0NL3MHs-k68r-nCCe67F94SUj7c098ukqTp4C0RVQ7e6qyBogIC7DI0JJiPfoyhNYCsps9eSrjDwiBDnBuxd0)